{
  "symbol": "BWXT",
  "company": "BWX Technologies, Inc.",
  "generated_at": "2026-06-24T07:36:46.068Z",
  "event_count": 7,
  "events": [
    {
      "type": "pipeline_event",
      "ts": "2026-06-04T09:52:26.408Z",
      "stage": "scout",
      "outcome": "failed",
      "reason": null,
      "trigger": "[news_M&A] BWX Technologies Expands Nuclear Reach With Precision Deal And Navy Contracts",
      "source": "hunter"
    },
    {
      "type": "analyst_decision",
      "ts": "2026-05-22T06:31:40.244Z",
      "skip": true,
      "reason": "BWXT trades at a stretched 39x forward P/E following a 95% YoY run with zero insider buying and thin options liquidity. The dossier flags dilution risks and elevated execution expectations, failing to clear the 60-point threshold for publication.",
      "score": 25,
      "breakdown": {
        "smart_money": 0,
        "options_flow": 0,
        "catalyst": 15,
        "mispricing": 0,
        "quality": 5,
        "technical": 5
      },
      "debug_path": "drafts/2026-05-22-BWXT.analyst.debug.json"
    },
    {
      "type": "scout_dossier",
      "ts": "2026-05-22T06:30:50.519Z",
      "summary": "BWXT is a high-quality nuclear components manufacturer with strong Government Operations (naval nuclear reactors/fuel) and growing Commercial Operations (SMR fabrication). The stock has surged ~95% YoY on nuclear renaissance tailwinds but now sits near the top of its range. The Form 4 cluster in the last 14 days consists almost entirely of routine compensation events — RSU vesting by directors and option exercises by executives, all with SELL components at elevated prices. No genuine open-market insider BUY signal exists. Valuation is stretched (forward P/E ~39x, EV/EBITDA ~43x) relative to defense peers even accounting for nuclear premium. The M&A acquisition of Precision Components Group tests valuation limits per recent press coverage. Earnings have consistently beaten but the stock dropped post-Q1 report on guidance concerns.",
      "verdict": "range_bound_or_income",
      "confidence": 4,
      "tool_calls": 23,
      "walltime_min": 18,
      "debug_path": "dossiers/2026-05-22-BWXT.scout.debug.json"
    },
    {
      "type": "analyst_decision",
      "ts": "2026-05-15T09:50:14.980Z",
      "skip": true,
      "reason": "BWXT lacks insider buying, shows material executive selling, trades at a stretched 40.6x forward P/E with no mispricing edge, and features low IV that makes income structures unattractive. Anti-signals (concentration, dilution) further negate any thesis.",
      "score": 5,
      "breakdown": {
        "smart_money": 0,
        "options_flow": 0,
        "catalyst": 5,
        "mispricing": 0,
        "quality": 0,
        "technical": 0
      },
      "debug_path": "drafts/2026-05-15-BWXT.analyst.debug.json"
    },
    {
      "type": "scout_dossier",
      "ts": "2026-05-15T09:49:43.168Z",
      "summary": "BWXT is a high-quality nuclear components manufacturer with strong government/defense revenue exposure (Navy nuclear propulsion — sole source) and a commercial SMR angle. The trigger was 10 Form 4 filings in 14 days, but after reading each filing: the CEO executed planned sales via a pre-set 10b5-1 plan worth ~$2M, the CFO exercised old options at sub-market prices and immediately diversified — both are neutral-to-mildly bearish signals. The other 8 filings were routine RSU grants to directors (deferred equity compensation). There are ZERO open-market insider purchases in the window. Meanwhile, valuation is stretched: forward P/E ~40.6x, EV/EBITDA ~44.8x, FCF yield <1%. Stock trades near all-time highs ($210 vs 52w high $241), RSI neutral at 47.5 with a recent bearish MACD cross, and is below its 50 DMA. The case for BWXT as an income/write vehicle exists given elevated IV on calls, but there is no mispricing anomaly and the smart-money signal was a false alarm.",
      "verdict": "range_bound_or_income",
      "confidence": 4,
      "tool_calls": 23,
      "walltime_min": 9,
      "debug_path": "dossiers/2026-05-15-BWXT.scout.debug.json"
    },
    {
      "type": "analyst_decision",
      "ts": "2026-05-08T14:38:54.794Z",
      "skip": true,
      "reason": "Extreme valuation premium (40x Fwd P/E, 44x EV/EBITDA) leaves no margin of safety, and the absence of insider buying alongside material insider selling negates smart-money support; the dossier correctly identifies no mispricing edge.",
      "score": 36,
      "breakdown": {
        "smart_money": 0,
        "options_flow": 1,
        "catalyst": 25,
        "mispricing": 0,
        "quality": 5,
        "technical": 5
      },
      "debug_path": "drafts/2026-05-08-BWXT.analyst.debug.json"
    },
    {
      "type": "scout_dossier",
      "ts": "2026-05-08T14:37:40.771Z",
      "summary": "BWXT is a high-quality nuclear components and government services firm with record backlog of $7.26B (+50% YoY), driven by U.S. Navy submarine procurement growth. The company just beat Q1 2026 EPS by +21% ($1.12 vs $0.93 est) on $860M revenue (+26% YoY), raised 2026 guidance above $3.75B, and announced $1.4B in new Naval Nuclear Propulsion Program contracts. However, the stock trades at ~40x forward P/E (vs defense sector median of ~22-25x) with EV/EBITDA of 44.6x — among the richest valuations in the industrials universe. The investigation trigger's Form 4 cluster consisted entirely of routine equity compensation events (RSU grants/deferrals to directors, option exercises by executives; code M=exercise, A=grant, not P=purchase), meaning there is no open-market insider buying signal. Options flow shows genuine bullish OI positioning but at strikes consistent with post-announcement hedging/rolls rather than a contrarian whale bet. The stock's recent -15% pullback from its $238 high to ~$207 is technically healthy; fundamentally, the company warrants premium multiples for its defense-nuclear moat — but at current levels there is no identifiable mispricing relative to that intrinsic value.",
      "verdict": "range_bound_or_income",
      "confidence": 4,
      "tool_calls": 25,
      "walltime_min": 20,
      "debug_path": "dossiers/2026-05-08-BWXT.scout.debug.json"
    }
  ],
  "lessons": [],
  "chart_signal": {
    "ticker": "BWXT",
    "call": "BUY",
    "confidence": 5,
    "score": 7,
    "factors": {
      "above_200dma": "+2",
      "above_50dma": "+1",
      "momentum_strong_up": "+2 (42.3%)",
      "rsi_neutral": "0 (60.6)",
      "macd_above_signal": "+1",
      "recent_macd_bullish_cross": "+1 (7d ago)",
      "from_high": "0 (-12.0%)"
    },
    "summary": "BUY (score +7) · 12-1 mom 42.3% · RSI 60.6 · above_both · -12.0% from high",
    "last_close": 209.89,
    "one_month_ago_close": 202.52,
    "twelve_month_ago_close": 142.31,
    "twelve_one_momentum_pct": 42.31,
    "rsi_14": 60.6,
    "ma_stack": "above_both",
    "from_period_high_pct": -11.97,
    "period_high": 238.42,
    "price_targets": {
      "bear": 166.89,
      "fair": 218.7,
      "bull": 290,
      "bear_return_pct": -20.5,
      "fair_return_pct": 4.2,
      "bull_return_pct": 38.2,
      "method": "street_targets ⨯ chart_floors",
      "street": {
        "target_low": 200,
        "target_mean": 238.79,
        "target_high": 290,
        "analyst_count": 13
      }
    },
    "generated_at": "2026-06-24T07:36:46.064Z"
  }
}